Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Pathogens

    Immune System Overreaction Contributes to Influenza Deaths

    By Global Biodefense StaffJuly 8, 2013
    Share
    Facebook LinkedIn Reddit Email

    H1N1 influenza virus particlesA new study by the National Institute of Allergy and Infectious Diseases (NIAID) shows that excessive early immune responses contribute to deaths caused by certain influenza viruses. Scientists found that reducing the number of inflammatory immune cells in the lungs of mice increased the animals’ survival after infection with a virulent flu strain, offering potential new strategies for flu treatment.

    Influenza viruses infect cells of the body’s respiratory system and rapidly multiply, causing damage to lung tissue.  However, the virus itself is not always to blame for the severity of flu symptoms. The immune system’s reaction to flu infection sometimes causes inflammation and additional lung damage.

    Although most influenza deaths occur in those with weakened immune systems, such as the elderly, certain flu viruses can cause death in young, healthy adults. Some studies have suggested that overreaction of the immune system contributes to the lethality of these highly virulent strains. Other work has shown that suppressing immune responses to the flu increases risk of death.

    Researchers led by NIAID’s Laboratory of Systems Biology infected mice with an influenza strain that mimics the effects of the H1N1 virus that caused the 1918 flu pandemic. In collaboration with researchers from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, they assessed the animals’ immune function at the gene, cell, and tissue levels and compared it to those of healthy mice and mice infected with a non-lethal H1N1 strain.

    Their initial studies suggested that infection-fighting immune cells called neutrophils may influence whether flu infections are deadly or not. Further analysis showed that neutrophils began to accumulate in the lungs of mice infected with the lethal flu strain within two days of infection—several days before the animals grew severely ill. The researchers found that the neutrophils release pre-formed proteins, such as the cytokine IL-1, and produce other chemicals that attract more neutrophils to the infection site in a potentially explosive amplification process. They predicted that blunting this amplification process might protect the mice from lethal immune damage.

    To test this prediction, the investigators reduced neutrophil numbers in infected mice by giving the animals a neutrophil-depleting antibody. Mice given low doses of the antibody survived longer than those that did not receive the antibody. However, animals treated with high doses of the antibody died prematurely, suggesting that too much neutrophil depletion may have interfered with beneficial immune responses.

    The study provides direct evidence in mice that damaging inflammation caused by the immune system’s initial response to H1N1 infection can be a major contributor to death. This work builds on previous studies by other investigators that revealed a correlation between early immune responses and the disease-producing capacity of viruses. The new findings raise the possibility that other infectious diseases that cause life-threatening lung injury, such as H7N9 influenza and SARS, might elicit similar immune reactions.

    Another novel finding from this study is that neutrophils continually produce IL-1. This raises the question of whether drugs that blunt the function of IL-1 might help limit neutrophil activation and subsequent lung damage in people with the flu while preserving the essential immune functions of IL-1. A few IL-1 inhibitors currently are FDA-approved to treat autoinflammatory diseases.

    The researchers report their results in this week in the journal Cell: A systems analysis identifies a feed-forward inflammatory circuit leading to lethal influenza infection.

    Source: NIAID

    Influenza
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleEPA Technologies for Chemical, Biological, Radiological Contamination Recovery
    Next Article Biodefense and Remediation of Drinking Water Systems

    Related Stories

    Healthcare Workers Express Outrage at Flawed CDC Mask Guidance

    September 18, 2023

    NIAID Seeks to Improve Computational Models of Influenza Immunity

    September 15, 2023

    Case Study: Fatal Avian Influenza Infection in Cat in Poland

    September 15, 2023

    Bird Flu Undergoing Changes That Could Increase Risk of Widespread Human Transmission

    September 14, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy